CEFOTAXIME Side Effects

6557209-0 | Body Temperature Increased, Rash Papular, Rash Pruritic
on Jan 27, 2010 Male patient from UNITED STATES , weighting 27.29 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Cefotaxime (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature increased, rash papular, rash pruritic. Cefotaxime dosage: 500mg 8 Hr Iv Bolus.

6520752-4 | Abdominal Distension, Biliary Tract Disorder, Blood Bilirubin Increased, Faeces Pale, Gamma-glutamyltransferase Increased, Hepatomegaly, Jaundice, Pyrexia, Vomiting
Patient was taking Cefotaxime (View Usage). Patient had the following side effects: abdominal distension, biliary tract disorder, blood bilirubin increased, faeces pale, gamma-glutamyltransferase increased, hepatomegaly, jaundice (What is jaundice?), pyrexia, vomiting on Dec 16, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 5.31 lb, was diagnosed with sepsis (What is sepsis?) and. Cefotaxime dosage: . During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ). Patient was hospitalized.

6260095-X | Convulsion, Encephalopathy, Restlessness
Adverse event was reported on Jun 17, 2009 by a Female patient taking Cefotaxime (View Usage) (Dosage: 1 G X 3/day) . Location: FRANCE , 80 years of age, After Cefotaxime was administered, patient had the following side effects: convulsion, encephalopathy, restlessness.

6260089-4 | Convulsion
on Jun 17, 2009 Female patient from FRANCE , 43 years of age, was treated with Cefotaxime (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Cefotaxime dosage: 1 G X 3/day,.


6258147-3 | Convulsion
on Jun 17, 2009 Male patient from FRANCE , 70 years of age, was treated with Cefotaxime (View Usage). Patient had the following side effects: convulsion. Cefotaxime dosage: .

6258142-4 | Convulsion, Encephalopathy, Restlessness
Patient was taking Cefotaxime (View Usage). After Cefotaxime was administered, patient had the following side effects: convulsion, encephalopathy, restlessness on Jun 17, 2009 from FRANCE Additional patient health information: Female patient , 80 years of age, . Cefotaxime dosage: 1 G X 3/day.

6258137-0 | Encephalopathy, Myoclonus
Adverse event was reported on Jun 17, 2009 by a Male patient taking Cefotaxime (View Usage) (Dosage: 4g/day) . Location: FRANCE , 84 years of age, Patient experienced the following unwanted or unexpected effects: encephalopathy, myoclonus.

6258134-5 | Disorientation, Hallucination
on Jun 17, 2009 Female patient from FRANCE , 67 years of age, was treated with Cefotaxime (View Usage). Patient had the following side effects: disorientation, hallucination. Cefotaxime dosage: 3g/day.

6258128-X | Convulsion
on Jun 17, 2009 Female patient from FRANCE , 43 years of age, was treated with Cefotaxime (View Usage). After Cefotaxime was administered, patient had the following side effects: convulsion. Cefotaxime dosage: 1 G X 3/day.

5895440-8 | Aspergillosis
Patient was taking Cefotaxime (View Usage). Patient experienced the following unwanted or unexpected effects: aspergillosis on Sep 17, 2008 from CHINA Additional patient health information: Female patient , 36 years of age, was diagnosed with rhinitis and. Cefotaxime dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PENICILLIN (View Penicillin Review and Penicillin Label ).

5566482-7 | Renal Failure Acute
Adverse event was reported on Dec 07, 2007 by a Female patient taking Cefotaxime (View Usage) (Dosage: Dose: Unk) . Location: UNITED KINGDOM , 13 years of age, Patient had the following side effects: renal failure acute. During the same period patient was treated with METRONIDAZOLE HCL (Dose: Unk) (View Metronidazole Hcl Review and Metronidazole Hcl Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), HYDROCORTISONE (Dose: Unk) (View Hydrocortisone Review and Hydrocortisone Label ), MESALAMINE (Dose: Unk) (View Mesalamine Review and Mesalamine Label ). Patient was hospitalized.

5491390-X | Decreased Appetite, Irritability, Meningitis Aseptic
on Oct 08, 2007 Male patient from JAPAN , child 1 years of age, was diagnosed with meningitis bacterial and was treated with Cefotaxime (View Usage). After Cefotaxime was administered, patient had the following side effects: decreased appetite, irritability, meningitis aseptic. Cefotaxime dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), PIPERACILLIN SODIUM (View Piperacillin Sodium Review and Piperacillin Sodium Label ), PANIPENEM (PANIPENEM) (View Panipenem (panipenem) Review and Panipenem (panipenem) Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ). Patient was hospitalized.

5280450-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Mar 19, 2007 Female patient from TURKEY , child 10 years of age, was diagnosed with pneumonia (What is pneumonia?), pleural effusion and was treated with Cefotaxime (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased. Cefotaxime dosage: Dose: Unk. During the same period patient was treated with VANCOMYCIN (Dose: Unk) (View Vancomycin Review and Vancomycin Label ).

5256784-6 | Clostridium Difficile Colitis, Inflammatory Bowel Disease
Patient was taking Cefotaxime (View Usage). Patient had the following side effects: clostridium difficile colitis, inflammatory bowel disease on Feb 28, 2007 from JAPAN Additional patient health information: Male patient , 14 years of age, was diagnosed with escherichia infection, gastrointestinal disorder and. Cefotaxime dosage: . Patient was hospitalized.

5208342-7 | Cardio-respiratory Arrest, Crying, Culture Urine Positive, Cyanosis, Escherichia Infection, Loss Of Consciousness, Nystagmus, Respiratory Rate Increased, Vomiting
Adverse event was reported on Jan 10, 2007 by a Male patient taking Cefotaxime (View Usage) (Dosage: 500 Mg Q8 Hour Iv) was diagnosed with escherichia infection, medulloblastoma and. Location: UNITED STATES , weighting 20.94 lb, After Cefotaxime was administered, patient had the following side effects: cardio-respiratory arrest, crying, culture urine positive, cyanosis, escherichia infection, loss of consciousness, nystagmus, respiratory rate increased, vomiting. During the same period patient was treated with VINCRISTINE (0.5 Mg X1 Iv) (View Vincristine Review and Vincristine Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ), NYSTATIN (View Nystatin Review and Nystatin Label ).

5207176-7 | Anaphylactic Reaction, Bronchospasm, Rash
on Jan 04, 2007 Male patient from , child 8 years of age, was diagnosed with meningococcal infection and was treated with Cefotaxime (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, bronchospasm, rash (What is rash?). Cefotaxime dosage: .

5125919-8 | Body Temperature Increased, Heart Rate Increased, Nausea, Rash
on Oct 03, 2006 Male patient from , 15 years of age, weighting 132.3 lb, was diagnosed with brain abscess, pain (What is pain?), vomiting and was treated with Cefotaxime (View Usage). Patient had the following side effects: body temperature increased, heart rate increased, nausea (What is nausea?), rash (What is rash?). Cefotaxime dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), BENZYLPENICILLIN (View Benzylpenicillin Review and Benzylpenicillin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CODIENE PHOSPHATE (View Codiene Phosphate Review and Codiene Phosphate Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

5001595-X | Von Willebrand's Disease
Patient was taking Cefotaxime (View Usage). After Cefotaxime was administered, patient had the following side effects: von willebrand's disease on Apr 27, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, was diagnosed with meningococcal sepsis and. Cefotaxime dosage: .

4989854-8 | Arthralgia, Malaise, Neutropenia, Pyrexia, Red Blood Cell Sedimentation Rate Increased, Skin Haemorrhage, Von Willebrand's Disease
Adverse event was reported on Apr 27, 2006 by a Male patient taking Cefotaxime (View Usage) (Dosage: Dose: Unk) was diagnosed with meningococcal sepsis and. Location: , 39 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia, malaise, neutropenia, pyrexia, red blood cell sedimentation rate increased, skin haemorrhage, von willebrand's disease.

4764807-3 | Cerebral Infarction, Encephalitis, Osteomyelitis, Rash Maculo-papular, Sinusitis
on Aug 30, 2005 Female patient from , child 11 years of age, weighting 132.3 lb, was diagnosed with osteomyelitis, encephalitis (What is encephalitis?), agitation and was treated with Cefotaxime (View Usage). Patient had the following side effects: cerebral infarction, encephalitis (What is encephalitis?), osteomyelitis, rash maculo-papular, sinusitis (What is sinusitis?). Cefotaxime dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CHLORAL HYDRATE (View Chloral Hydrate Review and Chloral Hydrate Label ). Patient was hospitalized.

4700556-5 | Hypocoagulable State, Thrombocytopenia
on May 20, 2005 Female patient from , 13 years of age, weighting 112.4 lb, was diagnosed with haemorrhage intracranial and was treated with Cefotaxime (View Usage). After Cefotaxime was administered, patient had the following side effects: hypocoagulable state, thrombocytopenia. Cefotaxime dosage: . During the same period patient was treated with NOVOSEVEN (47 Ug/kg, Tid) (View Novoseven Review and Novoseven Label ).

4685056-3 | Arthralgia, Eosinophilia, Rash, Transaminases Increased
Patient was taking Cefotaxime (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, eosinophilia, rash (What is rash?), transaminases increased on May 27, 2005 from Additional patient health information: Male patient , 56 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Cefotaxime dosage: Dose: Unk.

4673084-3 | Blister, Rash Erythematous, Rash Pruritic, Skin Exfoliation
Adverse event was reported on May 24, 2005 by a Female patient taking Cefotaxime (View Usage) (Dosage: 2 Gm Q8hr Intravenous) was diagnosed with cellulitis (What is cellulitis?) and. Location: , 73 years of age, Patient had the following side effects: blister, rash erythematous, rash pruritic, skin exfoliation.

4551387-0 | Clostridium Colitis
on Jan 04, 2005 Female patient from , 59 years of age, was diagnosed with ascites, sepsis (What is sepsis?), malnutrition, agitation, varices oesophageal, portal hypertension and was treated with Cefotaxime (View Usage). After Cefotaxime was administered, patient had the following side effects: clostridium colitis. Cefotaxime dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), THIAMINE (View Thiamine Review and Thiamine Label ), CHLORDIAZEPOXIDE (View Chlordiazepoxide Review and Chlordiazepoxide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).